Robot pancreas trial aims to tame tough diabetes

NCT ID NCT05562492

Ongoing Disease control Sponsor: University of Cambridge Source: ClinicalTrials.gov ↗

Summary

This study is testing if an automated 'closed-loop' insulin system works better than standard insulin therapy for people with diabetes caused by cystic fibrosis. About 128 young people and adults will use either the automated system or their usual insulin methods for 26 weeks. The main goal is to see which approach keeps blood sugar in a healthy range more consistently.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Addenbrooke's Hospital

Cambridge, CB2 0QQ, United Kingdom
All Wales Adult CF Centre

Cardiff, United Kingdom
Belfast City Hospital

Belfast, United Kingdom
Glenfield Hospital

Leicester, United Kingdom
Kings College Hospital

London, United Kingdom
Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom
Queen Elizabeth University Hospital

Glasgow, United Kingdom
Royal Brompton Hospital

London, United Kingdom
Royal Papworth Hospital

Cambridge, United Kingdom
Royal Stoke University Hospital

Stoke-on-Trent, United Kingdom
Southampton General Hospital

Southampton, United Kingdom
St Bartholomew's Hospital

London, United Kingdom
University Hospitals Bristol NHS Foundation Trust

Bristol, United Kingdom
Wythenshawe Hospital, Manchester University NHS Foundation Trust

Manchester, United Kingdom

Conditions

Explore the condition pages connected to this study.

CYSTIC FIBROSIS-RELATED DIABETES